After focusing on expanding Florida operations last month, Green Thumb Industries (CSE: GTII; OTCQX: GTBIF) is about to open another store in Pennsylvania next week, bumping up the company’s roster to seven total dispensaries statewide.
The newly-completed Rise Hermitage is scheduled to open its doors on Sept. 19, with an open house meet and greet for all community members to take place on Monday before cannabis products are on the shelves.
When it begins serving customers next Thursday, Rise Hermitage will officially become the first licensed Mercer County medical dispensary from a major producer.
Discussing the planned meet and great as well as the impact on the store’s opening for local community members, Hermitage Board of Commissioners member Bill Moder commented:
Aside from the upcoming Hermitage opening, Green Thumb currently operates a Pennsylvania manufacturing and processing site in Danville, as well as retail locations in Carlisle, Erie, Latrobe, Steelton, Mechanicsburg, and York.
Those stores stock the company’s Rhythm-branded product lines available for patients with qualifying conditions.
The state’s medical cannabis program is nearing 200,000 registered patients, with several thousand additional members signing up after the program was amended to include anxiety disorders and chronic pain in the current list of conditions.
In other company news, Chief Strategy Officer Jennifer Doole is appearing at the Females to the Front cannabis conference today and will speak on the subject of strategic alliances between marijuana-focused entities.
Like most other North American cannabis companies, Green Thumb Industries has a busy September business conference schedule, with Head of Capital Markets Andy Grossman additionally scheduled to appear at the Eight Capital Global Cannabis Conference next week.
Green Thumb’s stock price has been back on an upward trend since mid-August, now trading at $9.60 a share after a sharp fall from the $15 – $16 range back in April.
The opinions provided in this article are those of the author and do not constitute investment advice. Readers should assume that the author and/or employees of Grizzle hold positions in the company or companies mentioned in the article. For more information, please see our Content Disclaimer.